Sodium Selenite: Clinical Trials

11 trials of Sodium Selenite, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 unknown, 1 withdrawn. 4 Phase 3, 3 Phase 1, 3 Phase 2, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 34Completed 2, Unknown 2
Phase 13Completed 1, Unknown 1, Withdrawn 1
Phase 23Completed 2, Unknown 1
Phase 41Completed 1

Follow Sodium Selenite: new trials by email Literature Review of Sodium Selenite trials Research Report on Sodium Selenite

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone
Abiraterone Acetate, Sodium Selenite, Prednisone - Prostate Cancer, Castrate Resistant Prostate Cancer
Phase 1WithdrawnStanford University2020-10-012021-08-12
High Dose Inorganic Selenium for Preventing Chemotherapy Induced Peripheral Neuropathy
sodium selenite pentahydrate, Normal saline, Chemotherapy - Chemotherapy-induced Peripheral Neuropathy, Recurrent Ovarian Carcinoma
Phase 3UnknownSeoul National University Hospital682019-12-242023-06-26
Peripartum Cardiomyopathy in Nigeria Registry
Oral Sodium Selenite 200 µg/day for 3 months - Peripartum Cardiomyopathy
Phase 4CompletedAminu Kano Teaching Hospital1002017-06-122021-01-22
High-dose Selenium Supplementation in Patients With Left Ventricular Assist
Selenium Supplement (sodium selenite), Placebo - Ventricular Dysfunction, Left
Phase 3CompletedRWTH Aachen University212015-08-012018-02-07
SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial).
sodium selenite, Placebo - Heart Disease
Phase 3UnknownDaren K. Heyland14002015-01-012021-06-01
Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic Cancer
sodium selenite, radiation therapy, laboratory biomarker analysis - Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer
Phase 1CompletedStanford University152014-07-012024-05-28
Therapeutic Effect of Sodium Selenite on Oxidative Stress in Patients With Severe Sepsis
sodium selenite pentahydrate, placebo - continuous saline NaCl 50 ml - Severe Sepsis
CompletedPavol Jozef Safarik University42013-12-012017-04-10
Sodium Selenite as a Cytotoxic Agent in Advanced Carcinoma
Sodium selenite (Introselen), Sodium selenite - Malignant Tumor, Treatment Resistant Disorders
Phase 1 / Phase 2UnknownKarolinska University Hospital322007-02-012013-10-10
Selenium in the Treatment of Arsenic Toxicity and Cancers
sodium selenite, placebo - Arsenical Melanosis, Arsenical Keratosis
Phase 3CompletedTexas Tech University8192006-12-012011-10-07
The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer
sodium selenite - Breast Neoplasms, Lymphedema
Phase 2CompletedUniversity Health Network, Toronto342004-01-012010-08-13
Selenium, as Sodium Selenite, in the Treatment of Septic Shock
Selenium as sodium selenite - Septic Shock, Severe Sepsis
Phase 2CompletedCentre Hospitalier de Meaux602002-01-012005-09-21

Conditions studied

Prostatic Neoplasms (2)  ·  Sepsis (2)  ·  Arsenic Poisoning (1)  ·  Breast Neoplasms (1)  ·  Disease Progression (1)  ·  Fallopian Tube Neoplasms (1)  ·  Heart Diseases (1)  ·  Heart Failure (1)  ·  Lymphedema (1)  ·  Multiple Myeloma (1)  ·  Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Peripartum Cardiomyopathy (1)  ·  Peripheral Nervous System Diseases (1)  ·  Plasmacytoma (1)

Sponsors

Stanford University (2)  ·  Aminu Kano Teaching Hospital (1)  ·  Centre Hospitalier de Meaux (1)  ·  Daren K. Heyland (1)  ·  Karolinska University Hospital (1)  ·  Pavol Jozef Safarik University (1)  ·  RWTH Aachen University (1)  ·  Seoul National University Hospital (1)  ·  Texas Tech University (1)  ·  University Health Network, Toronto (1)

Countries

Canada (2)  ·  Germany (2)  ·  Bangladesh (1)  ·  France (1)  ·  Nigeria (1)  ·  Slovakia (1)  ·  South Korea (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Christian Stoppe, MD (2)  ·  Andreas Goetzenich, MD, PhD (1)  ·  Bernard J McDonald, MD (1)  ·  Daren K Heyland, MD (1)  ·  Eric Bellissant, MD, PhD (1)  ·  Hee Seung Kim, MD/PhD (1)  ·  Julian E Spallholz, PhD (1)  ·  Kamilu M Karaye, PhD (1)  ·  Ola Brodin, MD, PhD (1)  ·  Paul F La Porte, PhD (1)  ·  Selim Ahmed, MBBS, FCPS (1)  ·  Susan J Knox (1)  ·  Susan Knox (1)  ·  Wilfred Levin, MD (1)  ·  Xavier Forceville, MD (1)

Results publications

PMID 17617901, PMID 21121149, PMID 25020262, PMID 25169040, PMID 33087055, PMID 33397290, PMID 34132071, PMID 36630120, PMID 36827018, PMID 41630017, PMID 42466520, PMID 42622119

NIH funding

P30CA124435 (1), R21CA117111 (1)